Investor Group Named Lead Plaintiff In Drug Company’s Stock Drop Suit

Mealey's (December 12, 2017, 1:28 PM EST) -- SAN FRANCISCO — An investor group is the most appropriate candidate for lead plaintiff because it has the largest financial stake in the litigation and meets all other statutory requirements to...
To view the full article, register now.